妊娠期糖尿病中患者miR-138-5p通过调控缺氧诱导因子1α保护β细胞功能

doi:10.12092/j.issn.1009-2501.2020.05.002

摘要/Abstract

摘要： 目的:探讨在妊娠期糖尿病(GDM)患者中miR-138-5p对胰岛β细胞功能的影响及其相关作用机制。方法:通过RT-qPCR对比15例GDM患者与15例的正常健康孕妇外周血中miR-138-5p的表达差异;miR-138-5p mimic及inhibitor分别转染入β细胞系INS-1细胞中,过表达或抑制其在该细胞中的表达水平,并通过RT-qPCR验证转染效率;利用MTT增殖实验、Annexin V-FITC凋亡实验及胰岛素释放实验分别检测miR-138-5p对INS-1细胞的增殖、凋亡和胰岛素释放能力的影响;通过miRNA靶基因预测软件TargetScan筛选miR-138-5p的目标靶基因,并利用双荧光素酶基因报告及Western blot实验进行验证;功能挽救实验证实miR-138-5p是否通过靶向调控其目标基因而发挥对INS-1细胞的增殖、凋亡及胰岛素释放能力影响;Western blot实验检测miR-138-5p在INS-1细胞中作用的分子信号通路。结果:与正常健康孕妇相比,GDM患者外周血中miR-138-5p的表达显著低表达;在INS-1细胞中转染miR-138-5p mimic及inhibitor后可显著促进或抑制miR-138-5p的表达;过表达miR-138-5p可明显促进INS-1细胞的增殖,抑制其发生凋亡并促进细胞对胰岛素的释放能力;而下调miR-138-5p的表达,可显著抑制INS-1细胞的增殖,促进其发生凋亡及抑制细胞的胰岛素释放能力;通过miRNA靶基因预测软件TargetScan筛选缺氧诱导因子1α(hypoxia-inducible factor-1α, HIF-1α)为miR-138-5p的目标靶基因,双荧光素酶基因报告实验及Western blot实验提示miR-138-5p可抑制INS-1细胞中HIF-1α的表达;功能挽救实验证实miR-138-5p通过调控HIF-1α的表达,影响INS-1细胞的增殖、凋亡及胰岛素释放能力;Western blot实验明确miR-138-5p可能通过靶向调控HIF-1α的表达,影响PI3K/AKT信号通路中PI3K、AKT及其磷酸化后的p-PI3K、p-AKT蛋白而发挥对INS-1细胞的作用。结论:在GDM患者中,miR-138-5p可能通过靶向调控HIF-1α的表达,进而影响PI3K/AKT信号通路,促进β细胞的增殖、抑制其凋亡,并促进其胰岛素释放能力从而保护β细胞的功能。

关键词: 妊娠期糖尿病, miR-138-5p, HIF-1α, INS-1细胞, PI3K/AKT信号通路

Abstract: AIM: To study the effect of miR-138-5p on the function of β cell in gestational diabetes mellitus (GDM) and its related mechanism. METHODS: The expression of miR-138-5p in peripheral blood of 15 GDM pregnant women and 15 normal pregnant women were compared by RT-qPCR. miR-138-5p mimic and inhibitor were transfected into INS-1 cells, respectively, and their expression level was over expressed or inhibited. RT-qPCR was used to verify the transfection efficiency.MTT proliferation experiment, Annexin V-FITC apoptosis experiment and insulin release experiment were used to detect the effects of miR-138-5p on INS-1 cell proliferation, apoptosis and insulin release ability. The target gene of miR-138-5p was screened by TargetScan, a miRNA target gene prediction software. The functional rescue experiment confirmed whether miR-138-5p could exert its influence on INS-1 cell proliferation, apoptosis and insulin release ability by targeting its target gene. Western blot was used to detect the molecular signaling pathway of miR-138-5p in INS-1 cells. RESULTS: The expression of miR-138-5p in peripheral blood of GDM pregnant women was significantly lower than that of normal pregnant women. RT-qPCR showed that miR-138-5p mimic and inhibitor could significantly promote or inhibit the expression of miR-138-5p in INS-1 cells. The results of MTT proliferation experiment, Annexin V-FITC apoptosis experiment and insulin release experiment indicated that over expression of miR-138-5p could significantly promote the proliferation of INS-1 cells, inhibit the apoptosis of cells and promote the insulin release ability of cells. However, down-regulating the expression of miR-138-5p could significantly inhibit the proliferation of INS-1 cells, promote apoptosis and inhibit insulin release. HIF-1α was selected as the target gene of miR-138-5p by TargetScan. The double luciferase gene report and Western blot showed that miR-138-5p could inhibit the expression of HIF-1α in INS-1 cells. The functional rescue experiment confirmed that miR-138-5p could affect the proliferation, apoptosis and insulin release of INS-1 cells by regulating the expression of HIF-1α. Western blot showed that miR-138-5p may play a role in INS-1 cells by affecting PI3K, Akt and p-PI3K, p-Akt protein after phosphorylation in PI3K/Akt signaling pathway. CONCLUSION: miR-138-5p may reguLate HIF-1α expression in a targeted manner, thereby affecting the PI3K/AKT signaling pathway, promoting the proliferation and inhibition of the parent cells' apoptosis, and promoting their insulin-releasing ability to protect the function of β cell in GDM.

Key words: gestational diabetes mellitus, miR-138-5p, HIF-1 α, INS-1 cells, PI3K/Akt signaling pathway

中图分类号:

R965.2

黄好, 肖芳, 贾虹, 王晓霜, 段亚亭. 妊娠期糖尿病中患者miR-138-5p通过调控缺氧诱导因子1α保护β细胞功能[J]. 中国临床药理学与治疗学, 2020, 25(5): 489-497.

HUANG Hao, XIAO Fang, JIA Hong, WANG Xiaoshuang, DUAN Yating. miR-138-5p protects β cell function by regulating HIF-1α in gestational diabetes mellitus[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(5): 489-497.

参考文献

[1]张娅, 徐先明. 妊娠期糖尿病病因学研究进展 [J]. 中国实用妇科与产科杂志, 2013, 29(4): 299-302.
[2]郭娜, 刘静, 计静, 等. 妊娠期糖尿病孕妇胰岛素治疗对妊娠结局及安全性影响 [J]. 长春中医药大学学报, 2019, 35(6): 1146-1148.
[3]Dias S, Pheiffer C, Abrahams Y, et al. Molecular biomarkers for gestational diabetes mellitus [J]. Int J Mol Sci, 2018, 19(10): E2926.
[4]Catov JM, Parker CB, Gibbs BB, et al. Patterns of leisure-time physical activity across pregnancy and adverse pregnancy outcomes [J]. Int J Behav Nutr Phys Act, 2018, 15(1): 68.
[5]吴芳芳, 江文静. 妊娠期糖尿病孕妇外周血中Cfp-mRNA、Cff-DNA及VEGF、SFlt-1水平的变化趋势 [J]. 空军医学杂志, 2019, 35(5): 425-428.
[6]郑文霞, 吴方建. 1例糖尿病伴胰岛素抵抗患者的药学监护 [J]. 医药导报, 2017, 36(1): 99-101.
[7]Jiang Z, Yao L, Ma H, et al. miRNA-214 Inhibits cellular proliferation and migration in glioma cells targeting caspase 1 involved in pyroptosis [J]. Oncol Res, 2017, 25(6): 1009-1019.
[8]Yu C, Wang M, Li Z, et al. MicroRNA-138-5p regulates pancreatic cancer cell growth through targeting FOXC1 [J]. Cell Oncol, 2015, 38(3): 173-181.
[9]刘娇, 韩莹, 张云山. 微小RNA与妊娠期糖尿病的研究进展 [J]. 国际妇产科学杂志, 2018, 45(2): 133-135.
[10]杨伟, 张娜, 金丽娟, 等. Hsa-microRNA-138-5p抑制胃癌细胞增殖与糖代谢机制探讨 [J]. 中华肿瘤防治杂志, 2019, 26(1): 19-23.
[11]徐慧, 陈凤干, 王静, 等. 妊娠期糖尿病孕妇胎盘中HIF-1α、ET-1及VEGF的表达及与妊娠结局的关系研究 [J]. 现代生物医学进展, 2018, 18(17): 3323-3326.
[12]周丹, 张立婷, 李俊峰, 等. 缺氧诱导因子1α在肝纤维化发生发展中的作用机制 [J]. 临床肝胆病杂志, 2019, 35(7): 1604-1607.
[13]杨晓菊, 杨宗利, 王学芹, 等. HIF-1α、VEGF在妊娠期糖尿病胎盘组织中的表达及其与胎儿缺氧的关系 [J]. 实用妇产科杂志, 2012, 28(11): 962-966.
[14]Dincer UD. Fetal exposure to a diabetic intrauterine environment resulted in a failure of cord blood endothelial progenitor cell adaptation against chronic hypoxia [J]. Stem Cells Cloning, 2015, 8: 1-14.
[15]王芸, 石中华. 妊娠期糖尿病的两种不同诊断标准对围产期母婴结局的影响 [J]. 南京医科大学学报(自然科学版), 2013, 33(11): 1576-1579.
[16]Zheng S, Feng Q, Cheng J, et al. Maternal resveratrol consumption and its programming effects on metabolic health in offspring mechanisms and potential implications [J]. Biosci Rep, 2018, 38(2): R20171741.
[17]Oeregaard AH, Schrölkamp M,Kelstrup L,et al.Azadeh HOeregaard Increased expression of microRNA-15a and microRNA-15b in skeletal muscle from adult offspring of women with diabetes in pregnancy [J]. Hum Mol Genet, 27(10): 1763-1771.
[18]Tryggestad JB, Vishwanath A, Jiang S, et al. Influence of gestational diabetes mellitus on human umbilical vein endothelial cell miRNA [J]. Clin Sci (Lond), 2016, 130(21): 1955-1967.
[19]丁榕, 张勇, 张军玉, 等. miR-138-5p抑制滋养层细胞Vimentin表达并调节细胞侵袭和增殖的研究[J]. 中国临床医生杂志, 2018, 46(10): 1229-1232.
[20]王晓妮, 朱兵, 陈卓玥, 等. miR-138-5p对高糖诱导的人肾小管上皮细胞间充质转化的影响 [J].中国糖尿病杂志, 2018, 26(1): 64-68.
[21]杨晓菊, 徐琳, 杨宗利, 等. 妊娠期糖尿病胎盘组织缺氧诱导因子1α及血管内皮生长因子的表达与妊娠结局的关系 [J]. 中华糖尿病杂志, 2013, 5(5): 287-292.
[22]Li HP, Chen X, Li MQ. Gestational diabetes induces chronic hypoxia stress and excessive inflammatory response in murine placenta [J]. Int J Clin Exp Pathol, 2013, 6(4): 650-659.
[23]虞姣姣, 杨洋, 刘莹, 等. 芍药苷通过PI3K/AKT/m-TOR信号途径抑制肥大细胞活化脱颗粒 [J]. 中国临床药理学与治疗学, 2019, 24(9): 961-968.
[24]Zhang J, Xu J, Dong Y, et al.Down-regulation of HIF-1alpha inhibits the proliferation, migration, and invasion of gastric cancer by inhibiting PI3K/AKT pathway and VEGF expression [J]. Biosci Rep, 2018, 38(6)BSR20180741.
[25]Zhang HX, Yang JJ, Zhang SA, et al. HIF-1alpha promotes inflammatory response of chronic obstructive pulmonary disease by activating EGFR/PI3K/AKT pathway [J]. Eur Rev Med Pharmacol Sci, 2018, 22(18): 6077-6084.